MAP2K4 and neoplasm: Using the OncoScan assay on tumor DNA from 61 participants, we identified focal homozygous deletions in <i>BRCA1, BRCA2, MAP2K4, PTEN, RB1, SLX4, STK11, CREBBP</i> , and <i>NF1</i> .